Showing results 1 to 1 of 1
Title | Author(s) | Issue Date | |
---|---|---|---|
Efficacy and safety of single-agent sunitinib in treating patients with advanced hepatocelluar carcinoma after sorafenib failure: a prospective, open-label, phase II study Proceeding/Conference:Journal of Clinical Oncology | 2011 |